Lexicon Pharmaceuticals, Inc. (LXRX)
1.42
-0.07
(-4.70%)
USD |
NASDAQ |
Oct 23, 16:00
1.415
0.00 (0.00%)
Pre-Market: 20:00
Lexicon Pharmaceuticals Price to Book Value : 3.620 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.620 |
| October 22, 2026 | 3.799 |
| October 21, 2026 | 3.977 |
| October 20, 2026 | 4.028 |
| October 19, 2026 | 3.952 |
| October 16, 2026 | 3.875 |
| October 15, 2026 | 4.206 |
| October 14, 2026 | 4.079 |
| October 13, 2026 | 4.104 |
| October 12, 2026 | 4.206 |
| October 09, 2026 | 4.283 |
| October 08, 2026 | 4.487 |
| October 07, 2026 | 4.487 |
| October 06, 2026 | 4.461 |
| October 05, 2026 | 4.436 |
| October 02, 2026 | 4.640 |
| October 01, 2026 | 4.640 |
| September 30, 2026 | 4.780 |
| September 29, 2026 | 4.793 |
| September 28, 2026 | 4.844 |
| September 25, 2026 | 4.576 |
| September 24, 2026 | 4.742 |
| September 23, 2026 | 5.252 |
| September 22, 2026 | 5.558 |
| September 21, 2026 | 5.201 |
| Date | Value |
|---|---|
| September 18, 2026 | 5.226 |
| September 17, 2026 | 5.188 |
| September 16, 2026 | 5.150 |
| September 15, 2026 | 5.124 |
| September 14, 2026 | 5.048 |
| September 11, 2026 | 5.099 |
| September 10, 2026 | 5.150 |
| September 09, 2026 | 5.481 |
| September 08, 2026 | 5.685 |
| September 04, 2026 | 5.711 |
| September 03, 2026 | 5.762 |
| September 02, 2026 | 5.711 |
| September 01, 2026 | 5.583 |
| August 31, 2026 | 5.736 |
| August 28, 2026 | 5.838 |
| August 27, 2026 | 5.915 |
| August 26, 2026 | 5.889 |
| August 25, 2026 | 5.966 |
| August 24, 2026 | 5.915 |
| August 21, 2026 | 5.864 |
| August 20, 2026 | 5.558 |
| August 19, 2026 | 6.144 |
| August 18, 2026 | 6.170 |
| August 17, 2026 | 5.966 |
| August 14, 2026 | 5.915 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Bristol Myers Squibb Co. | 5.628 |
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
| Veru, Inc. | 1.346 |
| Johnson & Johnson | 7.789 |
Price to Book Value Related Metrics
| PS Ratio | 13.40 |
| Price | 1.42 |
| Earnings Yield | -10.77% |
| Market Cap | 631.81M |